The Valley Desk

ArticlePharmacoEconomics - openPublished

Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
PharmacoEconomics - open
Published
PubMed ID
36897427
PubMed Central ID
PMC10043099
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal